2018
DOI: 10.1016/j.amjoto.2018.06.020
|View full text |Cite
|
Sign up to set email alerts
|

Travel distance: Impact on stage of presentation and treatment choices in head and neck cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
36
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 26 publications
(36 citation statements)
references
References 13 publications
0
36
0
Order By: Relevance
“…White 2365 (30) 1429 (18) 1899 (24) 2073 (27) 1424 (20) 1552 (22) 1511 (22) 6976 Unknown 260 (32) 156 (19) 148 (18) 238 (30) 802 Unknown 139 (29) 74 (16) 103 (22) 156 ( 197 (19) 245 (23) 255 (24) patients with AML. For patients with ALL, this association holds for both children younger than 18 years and young adults aged 18 to 39 years.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…White 2365 (30) 1429 (18) 1899 (24) 2073 (27) 1424 (20) 1552 (22) 1511 (22) 6976 Unknown 260 (32) 156 (19) 148 (18) 238 (30) 802 Unknown 139 (29) 74 (16) 103 (22) 156 ( 197 (19) 245 (23) 255 (24) patients with AML. For patients with ALL, this association holds for both children younger than 18 years and young adults aged 18 to 39 years.…”
Section: Discussionmentioning
confidence: 99%
“…Interestingly, in some studies of adults with solid tumors, a longer distance to treatment centers seems to predict better outcomes. 20,21 For instance, among adults with head and neck cancer, those in the highest quartile for travel distance were more likely to present with early-stage disease, and those with oral cavity cancer were more likely to receive appropriate surgical therapy. 22 For men with prostate cancer, longer travel distances have been associated with decreased overall mortality except for those with Medicaid insurance.…”
Section: Continuedmentioning
confidence: 99%
See 1 more Smart Citation
“…Previous analyses have shown how demographic and socioeconomic markers such as insurance status, ethnicity, and hospital travel distance influence treatment access for head and neck cancer, and they have highlighted disparities in treatment access across the United States . Large database studies have found that patients with head and neck cancer with nonprivate insurance tend to receive care at hospitals with poorer outcomes in comparison with their privately insured counterparts .…”
Section: Discussionmentioning
confidence: 99%
“…9 Previous analyses have shown how demographic and socioeconomic markers such as insurance status, ethnicity, and hospital travel distance influence treatment access for head and neck cancer, and they have highlighted disparities in treatment access across the United States. [23][24][25][26][27] Large database studies have found that patients with head and neck cancer with nonprivate insurance tend to receive care at hospitals with poorer outcomes in comparison with their privately insured counterparts. 24 We observed that more upfront surgical therapy was seen in younger patients, female patients, patients with increased comorbidity scores, patients living in the Pacific regions of the United States, those traveling >25 miles for treatment, and patients treated at top-volume hospitals, regardless of whether they were academic or community institutions.…”
Section: Discussionmentioning
confidence: 99%